LabCorp wins FDA clearance for at-home COVID-19 test

2016 09 02 09 36 05 93 Fda Logo V2 400

LabCorp has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Pixel by LabCorp COVID-19 at-home test kit. The kit is the first to be approved by the FDA for self-collection of samples by patients at home.

The test kit can now be used by individuals to self-collect nasal swab specimens at home if recommended by a healthcare provider after completion of a COVID-19 questionnaire, according to LabCorp. Offered through the company's Pixel by LabCorp platform, the kits will initially be available to healthcare workers and first responders who may have been exposed to COVID-19 or may be symptomatic.

Consumers will be able to access the COVID-19 self-collection kits in the coming weeks, the vendor said.

Page 1 of 7
Next Page